Bayesian Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bayesian Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-29,538	Closed	-$632K	–	1176
2022 Q4	$632K	Sell	29,538 -29,500	-50%	-$630K	0.09%	293
2022 Q3	$1.06M	Buy	+59,038	New	+$775K	0.21%	129
2018 Q1	–	Sell	-15,756	Closed	-$49K	–	873
2017 Q4	$49K	Buy	+15,756	New	+$44.3K	0.01%	525

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bayesian Capital Management's ISEE Position: Q1 2023 in Review

Bayesian Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 29,538 shares — an estimated $632K sold.

Bayesian Capital Management first reported a position in ISEE in Q4 2017 and held it in 3 quarters. The position peaked at $1.06M in Q3 2022. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

Bayesian Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Bayesian Capital Management sold 29,538 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $632K.
Bayesian Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
Bayesian Capital Management's IVERIC bio, Inc. Common Stock position peaked at $1.06M in Q3 2022.
223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on Bayesian Capital Management's 13F filing for Q1 2023, filed 15 May 2023.